Aphios Logo1.jpg
Aphios Is Developing Pathogen Inactivation Technology For Human Plasma Units
26. September 2018 08:00 ET | Aphios
WOBURN, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Heart Lung...